当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Salwa Samir Anter
Propranolol is β-adrenergic receptor blocker with reported antioxidant effect and anti-inflammatory action , is used in treatment of the hypertension mainly, and main benefit in treatment patients with angina pectoris or myocardial infarction, add to role in central nervous system diseases as migraines and anxiety disorders, and tremor but rarely used in gynecology field in spite of many action either by beta receptor block or other mechanisms it acts with, such as anti _inflammatory, anticancer, antioxidant activity,pro_poptosis, and wound healing,
In this review, we have discussed the various aspects of propranolol that can be applied in clinical gynecology in number of ways such as local contraceptive, in the treatment of Vulovaginitis by affected main criteria of Trichomonas and Guardia lamblia ,which is motility ,propranolol inhibited motility of both organism and consequence inhibition of the growth of both organism, for the treatment of genital hemangioma,We have also shed some light on experimental studies _ such as its effect on polycystic ovary and endometriosis
Introduction:
Propranolol is a drug with beta blocker effect and used clinical in treated hypertension Thyrotoxicosis, and recent in capillary hemangiomas, anxiety, and essential tremors.(1) but clinical applications in gynecology is limited and route of administration oral route, injection but what about vagina route is used only as spermicidal effect